Hong Kong stocks fluctuate | Sino Biopharmaceutical (01801.HK) rises over 6% in early trading, unveiling the introduction of point-to-point coupled ADC technology. Two blockbuster pipeline drugs have the potential for overseas licensing.
According to the AI Finance APP, Sino Biopharmaceutical (01801.HK) rose more than 6% in the morning session, up 3.88% as of the time of writing, at HK$81.65, with a trading volume of HK$5.87 billion.
Latest
